FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2950576417> ?p ?o ?g. }

• W2950576417 endingPage "5572" @default.
• W2950576417 startingPage "5557" @default.
• W2950576417 abstract "Background/Aims: The tumor-suppressive functions of interferon regulatory factor 6 (IRF6) in some tumors have been preliminarily established, but its pathogenesis and underlying molecular mechanisms in breast cancer, the most common malignancy in women, remains poorly understood. Methods: Pairs of typical breast cancer cell lines (high- and low-aggressive) in addition to 27 breast cancer tissue samples and 31 non-cancerous breast tissues were used to investigate the expression level of IRF6 and Lentivirus-mediated gain-of-function studies, short hairpin RNA-mediated loss-of-function studies in vivo and in vitro were used to validate the role of IRF6 in breast cancer. Next, we performed RNA-Seq analysis to identify the molecular mechanisms of IRF6 involved in breast cancer progression. Results: Our findings showed that IRF6 was downregulated in highly invasive breast cancer cell lines but upregulated in poorly aggressive ones. Functional assays revealed that elevated IRF6 expression could suppress cell proliferation and tumorigenicity, and enhanced cellular chemotherapeutic sensitivity. To identify the molecular mechanisms involved, we performed a genome-wide and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis in breast cancer cells using RNA sequencing of gene expression profiles following the overexpression of IRF6. Genome-wide and KEGG analyses showed that IRF6 might mediate the PI3K-regulatory subunit PIK3R2, which in turn modulated the PI3K/AKT pathway to control breast cancer pathogenesis. Conclusion: We provide the first evidence of the involvement of IRF6 in breast cancer pathogenesis, which was found to modulate the PI3K/AKT pathway via mediating PIK3R2; indicating that IRF6 can be targeted as a potential therapeutic treatment of breast cancer." @default.
• W2950576417 created "2019-06-27" @default.
• W2950576417 creator A5005087327 @default.
• W2950576417 creator A5011538072 @default.
• W2950576417 creator A5018093835 @default.
• W2950576417 creator A5022088702 @default.
• W2950576417 creator A5022091246 @default.
• W2950576417 creator A5028708371 @default.
• W2950576417 creator A5044726317 @default.
• W2950576417 creator A5056040956 @default.
• W2950576417 creator A5062676435 @default.
• W2950576417 creator A5068978573 @default.
• W2950576417 creator A5069689440 @default.
• W2950576417 creator A5087837180 @default.
• W2950576417 creator A5091457305 @default.
• W2950576417 date "2019-06-01" @default.
• W2950576417 modified "2023-09-24" @default.
• W2950576417 title "<p>Candidate tumor suppressor gene IRF6 is involved in human breast cancer pathogenesis via modulating PI3K-regulatory subunit PIK3R2 expression</p>" @default.
• W2950576417 cites W1481101138 @default.
• W2950576417 cites W1559145852 @default.
• W2950576417 cites W1589967043 @default.
• W2950576417 cites W1968913844 @default.
• W2950576417 cites W1978990512 @default.
• W2950576417 cites W1991264372 @default.
• W2950576417 cites W1997079322 @default.
• W2950576417 cites W1997847812 @default.
• W2950576417 cites W1999070116 @default.
• W2950576417 cites W2015721248 @default.
• W2950576417 cites W2027847170 @default.
• W2950576417 cites W2035145212 @default.
• W2950576417 cites W2036403224 @default.
• W2950576417 cites W2044702943 @default.
• W2950576417 cites W2049885346 @default.
• W2950576417 cites W2070732456 @default.
• W2950576417 cites W2084818879 @default.
• W2950576417 cites W2090587373 @default.
• W2950576417 cites W2093611018 @default.
• W2950576417 cites W2096642700 @default.
• W2950576417 cites W2097255042 @default.
• W2950576417 cites W2100305481 @default.
• W2950576417 cites W2102395429 @default.
• W2950576417 cites W2104118000 @default.
• W2950576417 cites W2105078817 @default.
• W2950576417 cites W2106036365 @default.
• W2950576417 cites W2106663556 @default.
• W2950576417 cites W2107831804 @default.
• W2950576417 cites W2108399976 @default.
• W2950576417 cites W2114941442 @default.
• W2950576417 cites W2121311779 @default.
• W2950576417 cites W2121409164 @default.
• W2950576417 cites W2126629482 @default.
• W2950576417 cites W2131036795 @default.
• W2950576417 cites W2131139098 @default.
• W2950576417 cites W2132443398 @default.
• W2950576417 cites W2141428376 @default.
• W2950576417 cites W2142204977 @default.
• W2950576417 cites W2142507662 @default.
• W2950576417 cites W2143204308 @default.
• W2950576417 cites W2147640266 @default.
• W2950576417 cites W2154745259 @default.
• W2950576417 cites W2154864587 @default.
• W2950576417 cites W2162338472 @default.
• W2950576417 cites W2167368929 @default.
• W2950576417 cites W2171092698 @default.
• W2950576417 cites W2259802687 @default.
• W2950576417 cites W2620930278 @default.
• W2950576417 cites W2765176484 @default.
• W2950576417 cites W2765780353 @default.
• W2950576417 cites W2766999568 @default.
• W2950576417 cites W2889646458 @default.
• W2950576417 cites W2943606118 @default.
• W2950576417 doi "https://doi.org/10.2147/cmar.s203060" @default.
• W2950576417 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6594015" @default.
• W2950576417 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31417306" @default.
• W2950576417 hasPublicationYear "2019" @default.
• W2950576417 type Work @default.
• W2950576417 sameAs 2950576417 @default.
• W2950576417 citedByCount "12" @default.
• W2950576417 countsByYear W29505764172020 @default.
• W2950576417 countsByYear W29505764172021 @default.
• W2950576417 countsByYear W29505764172022 @default.
• W2950576417 crossrefType "journal-article" @default.
• W2950576417 hasAuthorship W2950576417A5005087327 @default.
• W2950576417 hasAuthorship W2950576417A5011538072 @default.
• W2950576417 hasAuthorship W2950576417A5018093835 @default.
• W2950576417 hasAuthorship W2950576417A5022088702 @default.
• W2950576417 hasAuthorship W2950576417A5022091246 @default.
• W2950576417 hasAuthorship W2950576417A5028708371 @default.
• W2950576417 hasAuthorship W2950576417A5044726317 @default.
• W2950576417 hasAuthorship W2950576417A5056040956 @default.
• W2950576417 hasAuthorship W2950576417A5062676435 @default.
• W2950576417 hasAuthorship W2950576417A5068978573 @default.
• W2950576417 hasAuthorship W2950576417A5069689440 @default.
• W2950576417 hasAuthorship W2950576417A5087837180 @default.
• W2950576417 hasAuthorship W2950576417A5091457305 @default.
• W2950576417 hasBestOaLocation W29505764171 @default.
• W2950576417 hasConcept C104317684 @default.
• W2950576417 hasConcept C121608353 @default.

• next